June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
The Impact of Evidence Based Guidelines on Pediatric Orbital Cellulitis Management and Outcomes
Author Affiliations & Notes
  • Soman Khan
    The University of Texas at Austin Dell Medical School, Austin, Texas, United States
  • Travis Kozak
    The University of Texas at Austin Dell Medical School, Austin, Texas, United States
  • Natalie Weston
    The University of Texas at Austin Dell Medical School, Austin, Texas, United States
  • Wade Mincher
    The University of Texas at Austin Dell Medical School, Austin, Texas, United States
  • Footnotes
    Commercial Relationships   Soman Khan None; Travis Kozak None; Natalie Weston None; Wade Mincher None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5056. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Soman Khan, Travis Kozak, Natalie Weston, Wade Mincher; The Impact of Evidence Based Guidelines on Pediatric Orbital Cellulitis Management and Outcomes. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5056.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Orbital cellulitis is a potentially sight-threatening infection of the soft tissues of the orbit. The Guidelines for Management of Pediatric Orbital Cellulitis were developed in 2014 with the goal of consolidating management recommendations regarding appropriate antimicrobial stewardship through local culture data and recommendations for use of adjunctive therapies.

Methods : A retrospective chart review was conducted on pediatric patients diagnosed with imaging confirmed orbital cellulitis prior to guideline deployment (2009-2013, n = 46) and post guideline deployment (2014-2021, n = 74). Data was collected on patient age and sex, interventions such as initial inpatient antibiotics, use of nasal care regimen (oxymetazoline/nasal saline/fluticasone nasal), use of systemic steroids, incidence of surgical intervention, as well as outcome measures such as incidence of readmission and length of stay. A chi-square test of independence and unpaired t-test were used to assess changes in management and patient outcomes before and after guideline implementation. A Bonferroni correction was applied to all statistical analyses.

Results : A chi-square test of independence showed a significant association between guideline implementation and appropriate initial inpatient antibiotic selection, X2 (1, N = 120) = 7.56, p = .005. There was no significant association between guideline implementation and incidence of use of nasal care regimen X2 (1, N = 120) = 2.82, p = .093, guideline implementation and incidence of use of systemic steroids X2 (1, N = 120) = 0.07, p = .787, guideline implementation and occurrence of surgical intervention X2 (1, N = 120) = 0.03, p = .847, or guideline implementation and incidence of readmission X2 (1, N = 120) = 0.49, p = .482. Furthermore, an unpaired t-test revealed no significant difference in length of stay for patients treated before (M = 4.98; SD = 2.85) and after (M = 4.80; SD = 2.23) guideline implementation (t (118) = 0.39; p = .698).

Conclusions : The implementation of evidence-based guidelines for management of pediatric orbital cellulitis was successful in shifting physician behavior towards the use of appropriate initial inpatient antibiotics. However, this did not result in a significant change in outcome measures such as length of stay or readmission rate.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×